期刊文献+

治疗风湿免疫性疾病的新药研究进展 被引量:4

下载PDF
导出
摘要 风湿免疫性疾病是一类慢性进行性疾病,病程迁延。药物治疗是风湿免疫性疾病治疗的最基本、最主要手段。常用的非甾体抗炎药、改善病情的抗风湿药、糖皮质激素已不能满足治疗要求,以生物制剂为代表的新药正走向历史舞台。
作者 龚毅 鲁卓林
机构地区 天津市儿童医院
出处 《天津药学》 2014年第1期52-56,共5页 Tianjin Pharmacy
  • 相关文献

参考文献37

  • 1Daniel J,Edward H,Andreas O,et al. Long- Term Safety and Efficacy of Rilonacept in Patients with Systemic Juvenile Idiopathic Arthritis[ J]. ARTHRITIS & RHEUMATISM ,2013,65:2486.
  • 2Buck/and J. Paediatric rheumatology: Biologic therapy for systemic ju- venile idiopathic arthritis-times they are a'changing[ J]. Rheumatolo- gy,2013,9 : 1759.
  • 3Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome[J]. Nat Clin Pract Rheunmtol,2006 ,2 :28.
  • 4Mellins E D, Macaubas C,Grom A A. Pathogenesis of systemic juvenile idiopathic: arthritis: some answers, more questions[ J]. Nat Rev Rheu- mato1,2011,7:416.
  • 5Hashkes P J, Laxer R M. Medical treatment of juvenile idiopathic ar- thritis[ J ]. JAMA ,2005,294 : 1671.
  • 6Giannini E H, Ruperto N, Ravelli A,et al. Preliminary definition of im- provement in juvenile arthritis [ J ]. Arthritis Rheum, 1997,40 : 1202.
  • 7Hashkes P J, Laxer R M. Medical treatment of juvenile idiopathic arthritis[ J ]. JAMA ,2005,294 : 1671.
  • 8De Benedetti F, Brunner H,Allen R,et al. Tocilizumab is efficacious in patients with systemic juvenile idiopathic arthritis across baseline demo- graphic and disease characteristics and prior/baseline treatments [ J ]. Arthritis Rheum,2011,63 (s) : 1029.
  • 9Dinarello C A. Blocking IL - 1 in systemic inflammation[ J]. Exp Med, 2005,201:1355.
  • 10Pascual V, Allantaz F, Arce E,et al. Role of interleukin - 1 ( IL - 1 ) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clini- cal response to IL- 1 blockade[J]. Exp Med,2005,201:1479.

同被引文献94

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部